TCTMD

Amulet IDE: LAA Occluder Performs Well Against Watchman

(UPDATED) In patients undergoing left atrial appendage (LAA) occlusion, the Amplatzer Amulet device (Abbott) provides better closure as well as noninferior safety and effectiveness compared with the ...
MedPage Today

Is LAA Closure With Amulet Less Leaky?

In the showdown between left atrial appendage (LAA) closure devices, the Amplatzer Amulet outperformed Watchman for peridevice leaks (PDL) in one trial longer term but not in another. At 12 months of ...
Business Wire

Largest Observational Study to Date of the St. Jude Medical AMPLATZER Amulet Left Atrial Appendage Occluder Demonstrates High Implant Success and Strong Safety Profile

Initial results from more than 800 atrial fibrillation patients presented at Transcatheter Cardiovascular Therapeutics 2016 indicate the AMPLATZER™ Amulet™ LAA Occluder is a safe alternative to ...
TCTMD

FDA Approves Amplatzer Amulet LAA Occluder

Photo Credit: Hermiller J. AMULET: device characteristics, procedural technique, clinical outcomes, and ongoing studies. Presented at: TCT 2019. The US Food and Drug Administration has approved the ...
MedPage Today

TCT: Amulet LAA Occluder Hot on the Heels of Watchman

WASHINGTON -- The Amplatzer Amulet left atrial appendage (LAA) occlusion device exhibited high closure rates and was tied to few early adverse events, the lead investigator of the AMULET study ...
Healio

Head-to-head trial of LAA closure devices yields mixed results: SWISS-APERO

Please provide your email address to receive an email when new articles are posted on . In a head-to-head trial of the Amplatzer Amulet and Watchman FLX left atrial appendage closure devices, the ...
Nasdaq

Abbott's (ABT) Amplatzer Amulet Occluder Trial Data Favorable

Abbott Laboratories ABT recently presented late-breaking data from the Amulet LAA Occluder IDE trial comparing the company's Amplatzer Amulet Left Atrial Appendage (LAA) Occluder with Boston ...
Medscape

Amulet and Watchman Equal for Left Atrial Appendage Closure

SAN FRANCISCO — Thirteen months after percutaneous left atrial appendage closure (LAAC), outcomes did not differ whether closure was performed using the Amulet (Abbott Cardiovascular) or the Watchman ...
Medscape

Defying Hopes, Dual Antiplatelets May Be Needed With LAA-Closure Devices in AF

VIENNA, AUSTRIA — Thrombi were sometimes found on two left-atrial-appendage (LAA) occluder devices in the weeks following implantation in two large registry studies of patients with atrial ...
News Medical

Clinical trial compares Amulet with Watchman FLX device for percutaneous left atrial appendage closure

SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency after percutaneous LAA closure ...
BioWorld

FDA approves Abbott's Amplatzer Amulet LAA occluder for afib

Abbott Laboratories received FDA approval for its Amplatzer Amulet left atrial appendage occluder to treat people with atrial fibrillation who are at risk of ischemic stroke about a month earlier than ...